Trading update March 2022

16 March 2022 Green Cross Health (NZX:GXH) continues to experience higher than anticipated revenue and profitability relative to the prior period. For the 11 months to 28 February 2022, the company has experienced an increase in revenue of approximately 16%. Group CEO Rachael Newfield said "COVID-19 related activity across the company's three divisions of Medical, Pharmacy and Community Health as well as the impact of recent acquisitions in the Medical division, continue to be the key contributors to the elevated performance levels. The company notes that this level of performance is not expected to continue into the next financial year." Net Profit After Tax Attributable to Shareholders for the 12 months to 31 March 2022 is projected to exceed the prior period result by $9.0m - $10.5m1 (25 January 2022 guidance $4.5m - $6.5m increase on prior period). Green Cross Health is scheduled to release its audited full year result for the year to 31 March 2022 on 27 May 2022. 1 $10.5m - $12.0m excluding extraordinary amounts. ENDS Contact: Ben Doshi ben.doshi@gxh.co.nz Rachael Newfield rachael.newfield@gxh.co.nz About Green Cross Health Green Cross Health (NZX: GXH) is a trusted New Zealand primary healthcare provider with multidisciplinary healthcare teams with the purpose of working together to support healthier communities. New Zealand owned and operated, Green Cross Health operates under branded groups Unichem and Life Pharmacies, The Doctors medical centres, Total Care Health community nursing services and Access Community Health to provide support, care and advice to diverse New Zealand communities. End CA:00388902 For:GXH Type:MKTUPDTE Time:2022-03-16 08:30:38